Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 in Japanese and Chinese Healthy Volunteers..

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 27, 2023

Primary Completion Date

December 4, 2023

Study Completion Date

December 4, 2023

Conditions

Healthy Participants

Interventions

DRUG

AZD5055

AZD5055 will be given orally to randomized participants as per the arm they are assigned.

DRUG

Placebo

Placebo will be given orally to randomized participants as per the arm they are assigned.

Trial Locations (1)

Research Site, Glendale